Predictors of Persistence With Antihypertensive Therapy: Results From the NHANES
Why the study?
What are the predictors of non-persistence with antihypertensive therapy in hypertensive patients?
Population
6,100 hypertensive patients from the United States who had been prescribed antihypertensive medication.
Design
Cross-sectional
Authors
Discussion
Loading...
Member takes
Implication
Identifies demographic and access barriers linked to antihypertensive non-persistence; leaves open targeted interventions pending prospective confirmation.
Structured PICO
What are the predictors of non-persistence with antihypertensive therapy in hypertensive patients?
P
Population
6,100 hypertensive patients from the United States (NHANES III and NHANES 1999-2002) who had been prescribed antihypertensive medication.
I
Intervention
Antihypertensive therapy (assessment of persistence)
O
Outcome
Non-persistence with prescribed antihypertensive medication
Young age, male sex, Hispanic ethnicity, low income, lack of health insurance, and infrequent doctor visits are major predictors of non-persistence with antihypertensive therapy in the US.
Cite This Study
Leonelo E. Bautista (2008) studied this question.